Abstract
Vascular smooth muscle cells (VSMC) are mature cells that maintain great plasticity. This distinctive feature is the basis of the VSMC migration and proliferation involved in cardiovascular diseases. We have used a proteomic approach to the molecular changes that promote the switch of VSMC from having a quiescent to activated-proliferating phenotype. In particular, we have focused on modulations occurring during tyrosine-phosphorylation following cell activation by serum or single growth factors, such as insulin-like growth factor 1 or platelet-derived growth factor. A comparison of two-dimensional polyacrylamide gel profiles from quiescent or activated-proliferating VSMC has allowed us to recognize a number of differences in protein expression. Several differentially expressed proteins have been identified by mass spectrometry, and their time-course changes during tyrosine-phosphorylation have been documented from time zero till 48 h after stimulation. We have documented a general decrease of the tyrosine-phosphorylation level within the first few minutes after stimulation followed by a recovery that is quick and dramatic for some chaperones and redox enzymes but not so significant for enzymes of glucose metabolism. With regard to cytoskeleton components, no remarkable fluctuations have been detected at the earliest time points, except for those relative to α-actin, which displays an impressive decrease. A comparison of the early stages of cell stimulation after the administration of serum or single growth factors has brought to light important differences in the phosphorylation of chaperones, thereby suggesting their crucial role in VSMC activation.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Barazi HO, Zhou L, Templeton NS, Krutzsch HC, Roberts DD (2002) Identification of heat shock protein 60 as a molecular mediator of α3β1 integrin activation. Cancer Res 62:1541–1548
Baserga R, Rubin R (1993) Cell cycle and growth control. Crit Rev Eukaryot Gene Expr 3:47–61
Bayes-Genis A, Conover CA, Schwartz RS (2000) The insulin-like growth factor axis: a review of atherosclerosis and restenosis. Circ Res 86:125–130
Candiano G, Bruschi M, Musante L, Cantucci L, Ghiggeri G, Carnemolla B, Orecchia P, Zardi L, Righetti PG (2004) Blue silver: a very sensitive colloidal Coomassie G-250 staining for proteome analysis. Electrophoresis 25:1327–1333
Cercek B, Sharifi B, Barath P, Bailey L, Forrester JS (1991) Growth factors in pathogenesis of coronary arterial restenosis. Am J Cardiol 68:24C–33C
Chamley-Campbell J, Campbell GR, Ross R (1979) The smooth muscle cell in culture. Physiol Rev 59:1–6
Christen T, Bochaton-Piallat ML, Neuville P, Renzen S, Redard M, Eys G van, Gabbiani G (1999) Cultured porcine coronary artery smooth muscle cells: a new model with advanced differentiation. Circ Res 85:99–107
Clemmons DR (1985) Exposure to platelet-derived growth factor modulates the porcine aortic smooth muscle cell response to somatomedin-C. Endocrinology 117:77–83
Delafontaine P, Bernstein KE, Alexander RW (1991) Insulin-like growth factor I gene expression in vascular cells. Hypertension 17:693–699
Delafontaine P, Song Y-H, Li Y (2004) Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels. Arterioscler Thromb Vasc Biol 24:435–444
Dupont A, Corseaux D, Dekeyzer O, Drobecq H, Guihot A-L, Susen S, Vincentelli A, Amouye P, Jude B, Pinet F (2005) The proteome and secretome of human arterial smooth muscle cells. Proteomics 5:585–596
Görg A, Postel W, Günther S (1988) The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 9:531–546
Hayashi K, Shibata K, Morita T, Iwasaki K, Watanabe M, Sobue K (2004) Insulin receptor substrate-1/SHP-2 interaction, a phenotype-dependent switching machinery of insulin-like growth factor-I signaling in vascular smooth muscle cells. J Biol Chem 279:40807–40818
Heldin CH, Westermarck B (1990) Platelet derived growth factor: mechanism of action and possible in vivo function. Cell Regul 1:555–566
Hochstrasser DF, Patchornik A, Merril CR (1988) Development of polyacrylamide gels that improve the separation of proteins and their detection by silver staining. Anal Biochem 173:412–423
Hogg PJ, Hotchkiss KA, Jimenez BM, Stathakis P, Chesterman CN (1997) Interaction of platelet-derived growth factor with thrombospondin 1. Biochem J 326:709–716
Kamide K, Hori MT, Zhu JH, Takagawa Y, Barrett JD, Eggena P, Tuck ML (2000) Insulin and insulin-like growth factor-I promotes angiotensinogen production and growth in vascular smooth muscle cells. J Hypertens 18:1051–1056
Kaplan-Albuquerque N, Bogaert YE, Van Putten V, Weiser-Evans MC, Nemenoff RA (2005) Patterns of gene expression differentially regulated by platelet-derived growth factor and hypertrophic stimuli in vascular smooth muscle cells: markers for phenotypic modulation and response to injury. J Biol Chem 280:19966–19976
McGregor E, Kempster L, Wait R, Welson SY, Gosling M, Dunn MJ, Powel JT (2001) Identification and mapping of human saphenous vein medial smooth muscle proteins by two-dimensional polyacrylamide gel electrophoresis. Proteomics 11:1405–1414
Owens GK, Kumar MS, Wamhoff BR (2004) Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 84:767–801
Patton WF, Erdjument-Bromage H, Marks AR, Tempst P (1995) Components of protein synthesis and folding machinery are induced in vascular smooth muscle cells by hypertrophic and hyperplastic agents. J Biol Chem 270:21404–21410
Pichon S, Bryckaert M, Berrou B (2004) Control of actin dynamics by p38 MAP kinase-Hsp27 distribution in the lamellipodium of smooth muscle cells. J Cell Sci 117:2569–2577
Pockley AG (2002) Heat shock proteins, inflammation, and cardiovascular disease. Circulation 105:1012–1017
Ross R (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. N Engl J Med 362:801–809
Roy S-G, Nozaki Y, Phan SH (2001) Regulation of alpha-smooth muscle actin gene expression in myofibroblast differentiation from rat lung fibroblasts. Int J Biochem Cell Biol 33:723–734
Rubini M, Werner H, Gandini E, Roberts CT, Leroith D, Baserga R (1994) Plateled-derived growth factor increases the activity of the promoter of the insulin-like growth factor-1 (IGF-1) receptor gene. Exp Cell Res 221:374–379
Shevchenko A, Wilm M, Vorm O, Mann M (1996) Mass spectrometric sequencing of proteins from silver-stained polyacrylamide gels. Anal Chem 68:850–858
Snoeckx LH, Cornelussen RN, Van Nieuwenhoven FA, Reneman RS, Van Der Vusse GJ (2001) Heat shock proteins and cardiovascular pathophysiology. Physiol Rev 81:1461–1497
Thyberg J, Hedin U, Sjölund M, Palmberg L, Bottger BA (1990) Regulation of differentiated properties and proliferation of arterial smooth muscle cells. Arteriosclerosis 10:966–990
Wilkinson B, Gilbert HF (2004) Protein disulfide isomerase. Biochim Biophys Acta 1699:35–44
Acknowledgments
We thank Dr. Dietmar Waidelich and Dr. Dietrich Merkel of Applied Biosystems for their collaboration and kind hospitality at their laboratories in Darmstadt (Germany). We are also grateful to Manuella Walker for helpful reading of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Additional information
This work was partially supported by two FIRB 2001 project grants to Dr. G. Rainaldi and to Prof. G. Camici.
Rights and permissions
About this article
Cite this article
Boccardi, C., Cecchettini, A., Caselli, A. et al. A proteomic approach to the investigation of early events involved in vascular smooth muscle cell activation. Cell Tissue Res 328, 185–195 (2007). https://doi.org/10.1007/s00441-006-0357-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00441-006-0357-3